Pretreatment with LA14 alleviated the upregulation of the focal adhesion pathway, the ECM (extracellular matrix)-receptor interaction pathway and the proteoglycans in the cancer pathway as well as the downregulation of the ascorbate and aldarate metabolism pathway, the cysteine and methionine metabolism pathway, the PPAR signaling pathway, and the peroxisome pathway. Here, PPARA is linked to cancer.